Case

A 48-year-old man presents to your ED complaining of a two-day history of a warm, painful, reddened area on his right shin. It started with a minor abrasion earlier in the week. He has no significant past medical history and no known drug allergies. There is no evidence of an abscess on examination, and his labs and vital signs are normal. He is diagnosed with uncomplicated cellulitis, and you plan to send him home with a five-day course of cephalexin but are thinking about giving him a “one for the road” single dose of IV cefazolin before he leaves.

ACEP Now features one article each issue related to an ACEP eCME CME activity. Log on to the ACEP eCME CME site to complete the activity for this article and earn free AMA PRA Category 1 Credit.

 

Question

What is the risk of emergency department patients developing antibiotic-associated diarrhea (AAD) with an IV dose of antibiotics prior to discharge?

Background

We all know that diarrhea is a common side effect of antibiotic therapy. The incidence reported in the literature is between 5 percent and 39 percent.¹ Clostridium difficile infection (CDI) is one of the most concerning types of AAD and has been increasing.²

A number of factors are known to increase the risk of AAD/CDI.³ These include the type of antibiotic used and the duration of therapy. While almost all antibiotics can cause AAD and CDI, the cephalosporins, broad-spectrum penicillins, and clindamycin are more often the cause.

There are some patient factors also thought to be associated with AAD/CDI. These are age greater than 65 years, comorbidities, and a history of AAD.

Relevant Article

Haran JP, Hayward G, Skinner S, et al. Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics. Am J Emerg Med. 2014;32(10):1195-1199.

• Population: Adult patients from three EDs.
  • Patients were excluded if they had diarrhea or C. difficile in the previous four weeks, had received an antibiotic in the previous four weeks, or were admitted to the hospital.
• Intervention: IV antibiotics as part of their ED visit and discharged home with a prescription for antibiotics.
• Comparison: Patients who were not given IV antibiotics as part of their ED visit and discharged home with a new prescription for antibiotics.
• Outcomes:
  • Primary outcome was the development of AAD (three or more loose stools per day for at least two days).
  • Secondary outcome was the development of CDI (AAD that led to a diagnosis of CDI confirmed by a positive C. difficile toxin A assay).
• Authors’ Conclusions: “Intravenous antibiotic therapy administered to ED patients before discharge was associated with higher rates of AAD and with two cases of CDI. Care should be taken when deciding to use broad-spectrum IV antibiotics to treat ED patients before discharge home.”
• Key Results: There were 247 patients included in the study. The most common infection being treated was a skin/soft tissue infection.
  • Primary outcome of antibiotic-associated diarrhea:
    • 45/247 (18 percent) odds ratio 2.73 (95 percent CI, 1.38–5.43)
    • 25.7 percent IV group versus 12.3 percent oral group
    • Absolute difference of 13.4 percent
    • Number needed to harm=7
  • Secondary outcome of C. difficile infection:
    • 2/247 (1 percent)

The rate of AAD increased with the duration of antibiotic therapy. Clindamycin, vancomycin, cephalosporins, penicillins, and macrolides were associated with the highest rates of AAD; quinolones and doxycycline had the lowest rates.